Scinai Bioservices Inc. has been established in Delaware as the company's new US-based subsidiary, which will serve biotech companies in early stage drug development.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

FDA Grants Approval to Kedrion to Produce PLGD-1 Therapeutic at Bolognana Plant

By Nicholas Saraceno

November 23rd 2024

FDA's approval will allow Kedrion to manufacture Ryplazim (plasminogen, human-tvmh), the only FDA-approved therapy for treating PLGD-1, at facility in Bolognana, Italy.

Sanofi Grows Antibody Production in France with €40 Million Investment

By Feliza Mirasol

November 22nd 2024

Sanofi will use this investment to increase its antibody bioproduction at its site in Lyon Gerland, France.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

CDMO SEKISUI Expands its CGMP Biopharma Manufacturing Capacity

By Feliza Mirasol

November 20th 2024

SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site.

Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing

By Feliza Mirasol

November 19th 2024

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.

More News

Engineered Oilbodies Produce Vaccines and Adjuvants 2

January 6th 2005

Engineered Oilbodies Produce Vaccines and Adjuvants

...

22 23 24 25 26

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777